1994
DOI: 10.1006/jmbi.1994.1284
|View full text |Cite
|
Sign up to set email alerts
|

The de Novo Design of an Antibody Combining Site

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
13
0

Year Published

1995
1995
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 42 publications
(15 citation statements)
references
References 0 publications
2
13
0
Order By: Relevance
“…deviation was 0.66A between the D1 domains determined in two crystal forms (Ryu, Truneh, Sweet & Hendrickson, 1994). The two V domains in protein Rei (Epp et al, 1975) and in protein War (Huang et al, 1994) and in protein M29b (Essen & Skerra, 1994) that were determined with higher, approximately 2,~,, resolution data are more similar to each other, the r.m.s, deviation is 0.35, 0.36 and 0.35 A, respectively. In general the cores of the domains with identical sequences became more similar with increased resolution of the diffraction data, and as the refinement progressed.…”
Section: Structure Determination: Molecular Replacementmentioning
confidence: 71%
“…deviation was 0.66A between the D1 domains determined in two crystal forms (Ryu, Truneh, Sweet & Hendrickson, 1994). The two V domains in protein Rei (Epp et al, 1975) and in protein War (Huang et al, 1994) and in protein M29b (Essen & Skerra, 1994) that were determined with higher, approximately 2,~,, resolution data are more similar to each other, the r.m.s, deviation is 0.35, 0.36 and 0.35 A, respectively. In general the cores of the domains with identical sequences became more similar with increased resolution of the diffraction data, and as the refinement progressed.…”
Section: Structure Determination: Molecular Replacementmentioning
confidence: 71%
“…There appears to be a wide range of interaction strengths and in one case there was little association at all [21], while in another the addition of isopropanol disrupted it extensively [22]. Hence, stabilization by scFv or dsFv approaches has been extensively pursued.…”
Section: Discussionmentioning
confidence: 99%
“…3 and S3, identified by their crystal structure PDB ID, are as follows: 2C1P, anti-finrozole (drug candidate); 75 3CFB, anti-trans-stilbene (blue fluorescent complex); 76 1FLR, anti-fluorescein (quenched fluorescent dye); 77 1LVE, LEN myeloma V L dimer; 78 1QAC, LEN Q89L mutant V L dimer; 24 2Q1E, amyloidogenic mutant V L dimer; 79 2RHE, Bence-Jones V L dimer; 80 1IVL, synthetic V L dimer. 81 …”
Section: Methodsmentioning
confidence: 99%